← All trials
NCT02625181
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2016
- Primary completion
- Jul 1, 2017
- Completion date
- Nov 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 32000
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Vanderbilt UniversityLead sponsor
- Vanderbilt UniversityOverall official - principal investigator
- Vanderbilt UniversityReponsible party - principal investigator
- University of WashingtonCollaborator
Drugs studied
- hydrocodone
- propofol
- urea
- ketamine
- alfentanil
- oxycodone
- dolasetron
- isoflurane
- sevoflurane
- granisetron
- haloperidol
- ramosetron
- palonosetron
- meperidine
- meclizine
- metoclopramide
- scopolamine
- sufentanil
- desflurane
- hydromorphone
- tropisetron
- ondansetron
- fentanyl
- methadone
- morphine
- droperidol
- promethazine hydrochloride
- aprepitant
- oxymorphone
- remifentanil
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.